『MENA MedTech Insights』のカバーアート

MENA MedTech Insights

MENA MedTech Insights

著者： Ran Chen
無料で聴く

このコンテンツについて

 Welcome to MENA MedTech Insights, the definitive podcast for professionals in the Middle East and North Africa's rapidly growing medical technology sector. Each episode, we explore the latest innovations, market trends, and regulatory landscapes, featuring exclusive interviews with the founders, investors, and leaders who are shaping the future of healthcare in the region.Copyright 2025 Ran Chen
エピソード
  • Pure Global Presents: Decoding Egypt's Arabic Labeling Requirements for Medical Devices – Your SEO Guide to MENA MedTech Market Entry

    Pure Global Presents: Decoding Egypt's Arabic Labeling Requirements for Medical Devices – Your SEO Guide to MENA MedTech Market Entry
    2025/08/25
    This episode of MENA MedTech Insights dives deep into a crucial, and often underestimated, aspect of entering the Egyptian medical device market: the strict Arabic labeling requirements set by the Egyptian Drug Authority (EDA). We explore the dual-language mandate and uncover the common pitfalls that can lead to significant delays and financial losses for manufacturers. Imagine your company has spent millions on product development and is ready to launch in Egypt, a key MENA market. Your shipment arrives but is held indefinitely at customs. The reason is a simple oversight where the device's instructions for use and outer packaging are only in English. This single compliance failure forces a complete repackaging effort, delaying your market entry by months and giving your competitors a critical advantage. This episode will help you avoid that exact scenario. Key Takeaways: - Why is dual-language labeling in both Arabic and English an absolute necessity for the Egyptian market? - What specific information must be translated on the primary label, the packaging, and the Instructions For Use (IFU)? - How do the Egyptian Drug Authority's UDI requirements integrate with existing labeling rules? - What are the most common mistakes foreign manufacturers make when designing their labels for Egypt? - Are internationally recognized symbols sufficient, or do they require an explanation in Arabic? - Beyond translation, what are the EDA’s expectations for the physical quality and design of the packaging itself? - How can a seemingly minor labeling error lead to major consequences like shipment rejection or product recalls? At Pure Global, we offer end-to-end regulatory consulting solutions for MedTech and IVD companies. We combine local expertise in over 30 markets, including Egypt, with advanced AI and data tools to streamline your global market access and ensure you get every detail right, from technical dossiers to local labeling. Contact us to ensure your product launch is a success at info@pureglobal.com or visit https://pureglobal.com/.
    続きを読む 一部表示
    3 分
  • Pure Global MENA MedTech Insights: Choosing Your Saudi Arabia Authorized Representative - The Critical SFDA Decision Between a Distributor and an Independent AR

    Pure Global MENA MedTech Insights: Choosing Your Saudi Arabia Authorized Representative - The Critical SFDA Decision Between a Distributor and an Independent AR
    2025/08/24
    In this episode of MENA MedTech Insights, we tackle a critical strategic decision for any medical device manufacturer looking to enter the Kingdom of Saudi Arabia: choosing your Authorized Representative (AR). This SFDA requirement is more than a formality; it's a choice that can define your operational freedom and long-term success in the market. We explore the two main pathways: appointing your distributor versus partnering with an independent, third-party AR. While naming your distributor seems convenient, it can lead to significant conflicts of interest and lock you into a single commercial partner, jeopardizing your market access if the relationship changes. This episode breaks down the risks and reveals why an independent AR provides the control and flexibility essential for sustainable growth. Imagine this: your MedTech product is gaining traction in Saudi Arabia, but your relationship with your distributor-AR sours. You try to switch partners, only to find your market registration is held hostage, forcing a costly and lengthy re-approval process. This episode explores how to avoid that exact scenario. What you'll learn in this episode: 1. What are the SFDA's core requirements for a medical device Authorized Representative? 2. Why might appointing your distributor as your AR create a major conflict of interest? 3. How can your choice of AR lock you into a single commercial partner and block your market flexibility? 4. What happens to your device registration (MDMA) if you part ways with your distributor-AR? 5. What are the strategic benefits of using an independent AR for long-term market control? 6. How does a neutral AR allow you to manage multiple distributors seamlessly? 7. What key questions should you ask before signing any AR agreement in Saudi Arabia? At Pure Global, we provide end-to-end regulatory consulting and act as your independent Authorized Representative in Saudi Arabia and over 30 markets worldwide. We combine local expertise with advanced AI to secure and maintain your market access, giving you full control over your commercial strategy. To learn more about how we can help you succeed in the MENA region, contact us at info@pureglobal.com or visit https://pureglobal.com/.
    続きを読む 一部表示
    3 分
  • Pure Global's MENA MedTech Insights: Navigating SFDA and UAE Medical Device Classes for Faster Market Access.

    Pure Global's MENA MedTech Insights: Navigating SFDA and UAE Medical Device Classes for Faster Market Access.
    2025/08/23
    This episode of MENA MedTech Insights dives deep into the complex world of medical device classification across the Middle East and North Africa. We move beyond the basics of risk-based classes to uncover the single most important factor for market access: reference country approvals. Learn how regulators in key markets like Saudi Arabia and the United Arab Emirates leverage prior approvals from the FDA, EU, and others to shape their registration pathways. We break down the specific requirements of the Saudi Food and Drug Authority (SFDA) and the UAE's Ministry of Health and Prevention (MOHAP). This episode provides manufacturers with the critical insights needed to avoid common pitfalls, reduce delays, and create an efficient, multi-country registration strategy for this lucrative but complex region. **Case Study Highlight:** Imagine your company's innovative Class IIa diagnostic device, which already has a CE Mark, gets stuck in the Saudi regulatory process for six months. The reason? A failure to properly format the technical dossier to SFDA standards and an overlooked requirement for local clinical data, costing you first-mover advantage and significant revenue. This episode is designed to help you prevent these exact scenarios. **本期干货 (Key Questions Answered):** 1. Why is a 'one-size-fits-all' regulatory approach doomed to fail in the MENA region? 2. What is a 'reference country approval' and why is it the key to unlocking market access in Saudi Arabia? 3. How do the SFDA's Class A, B, C, and D categories align with EU and FDA classifications? 4. What are the most common documentation mistakes that lead to delays with the UAE's MOHAP? 5. Does having FDA clearance automatically guarantee a fast registration in the Gulf countries? 6. How do local Authorized Representative requirements differ between key MENA markets? 7. What are the unique labeling and language requirements you must meet before shipping your product? 8. For a new Software as a Medical Device (SaMD), how do you determine its risk class for the SFDA? At Pure Global, we transform these regulatory complexities into clear pathways for market access. Our end-to-end solutions for MedTech and IVD companies combine deep local expertise with advanced AI tools to streamline your global expansion. Don't let regulatory hurdles dictate your growth. Contact our experts for a consultation at info@pureglobal.com or visit https://pureglobal.com/ to secure your market presence in the MENA region and beyond.
    続きを読む 一部表示
    3 分
まだレビューはありません